VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014

Oct 30, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-10-28

Reporting Person: Sachdev Amit (EVP, Policy, Access & Value)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-28	Common Stock	M	12000	$39.05	Acquired	50671	Direct
2014-10-28	Common Stock	S	12000	$115.00	Disposed	38671	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-28	Stock Option (right to buy)	$39.05	M	12000	Disposed	2020-02-03	Common Stock (12000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	882	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.

F2: Fully vested.